PTLA

Portola Pharmaceuticals, Inc. Competitors

$37.64
*  
1.95
5.46%
Get PTLA Alerts
*Delayed - data as of May 1, 2015  -  Find a broker to begin trading PTLA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Portola Pharmaceuticals, Inc.

CompanyName
Symbol: Market
LastSale ▼ NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 471.16 13.70 ▲ 709,630 $ 474.97
$ 462.45
$ 495.50
$ 269.50
153.97 47,419,898,200
Actavis, Inc.
ACT: NYSE
$ 289.74 6.88 ▲ 2,626,955 $ 290.01
$ 284.68
$ 317.72
$ 193
NE 113,502,747,600
Intercept Pharmaceuticals, Inc.
ICPT: NASDAQ-GS
$ 254.99 2.18 ▲ 474,745 $ 261.8999
$ 250.17
$ 349.08
$ 128.50
NE 5,715,600,850
Pharmacyclics, Inc.
PCYC: NASDAQ-GS
$ 254.51 -1.69 ▼ 1,034,300 $ 256.6098
$ 254
$ 260.47
$ 82.51
235.66 19,347,086,670
Shire plc
SHPG: NASDAQ-GS
$ 243.90 0.39 ▲ 656,227 $ 247.47
$ 242.61
$ 264.98
$ 156.25
13.41 48,712,195,800
Valeant Pharmaceuticals International, Inc.
VRX: NYSE
$ 223.02 6.09 ▲ 2,553,099 $ 223.37
$ 217.03
$ 227.76
$ 106
75.6 74,706,570,540
Puma Biotechnology Inc
PBYI: NYSE
$ 188.26 7.68 ▲ 372,600 $ 188.64
$ 183.01
$ 279.37
$ 53.63
NE 6,009,070,940
Perrigo Company
PRGO: NYSE
$ 186.26 2.98 ▲ 2,135,482 $ 186.86
$ 182.65
$ 215.73
$ 125.37
120.95 27,242,946,380
Jazz Pharmaceuticals plc
JAZZ: NASDAQ-GS
$ 180.74 2.04 ▲ 588,742 $ 182.77
$ 178.09
$ 191.005
$ 120.38
217.76 10,963,146,180
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 172.50 3.27 ▲ 954,324 $ 175
$ 170.42
$ 203.30
$ 147.81
59.08 34,870,702,500
United Therapeutics Corporation
UTHR: NASDAQ-GS
$ 170.92 11.23 ▲ 1,009,442 $ 173.70
$ 157.20
$ 190.29
$ 84.63
50.57 7,976,152,720
Receptos, Inc.
RCPT: NASDAQ-GS
$ 156.40 9.06 ▲ 743,840 $ 157.65
$ 150
$ 203.25
$ 24.5345
NE 4,927,538,400
Taro Pharmaceutical Industries Ltd.
TARO: NYSE
$ 141.41 0.80 ▲ 72,334 $ 142.99
$ 140.26
$ 173
$ 103.331
14.34 6,056,873,120
Vertex Pharmaceuticals Incorporated
VRTX: NASDAQ-GS
$ 125.60 2.32 ▲ 1,170,877 $ 125.97
$ 123.816
$ 137.50
$ 62.405
NE 30,406,378,400
Medivation, Inc.
MDVN: NASDAQ-GS
$ 125.41 4.67 ▲ 856,999 $ 125.83
$ 121.94
$ 141.58
$ 58.42
37.55 9,811,200,530
BioMarin Pharmaceutical Inc.
BMRN: NASDAQ-GS
$ 115.92 3.87 ▲ 1,861,150 $ 119.75
$ 112.61
$ 133.54
$ 55.36
NE 18,431,280,000
Mallinckrodt plc
MNK: NYSE
$ 114.20 1.02 ▲ 1,232,140 $ 115.955
$ 113.50
$ 134.2599
$ 67.18
NE 13,302,244,400
Celgene Corporation
CELG: NASDAQ-GS
$ 110.55 2.49 ▲ 6,592,052 $ 112
$ 108.02
$ 129.06
$ 71.315
37.73 88,505,335,050
GW Pharmaceuticals Plc
GWPH: NASDAQ-GM
$ 109.13 4.48 ▲ 459,850 $ 110.7271
$ 106.78
$ 126.78
$ 58.16
NE 2,152,152,730
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 106.89 5.02 ▲ 786,253 $ 107.11
$ 101.52
$ 132.99
$ 47.42
NE 8,953,106,400
Novartis AG
NVS: NYSE
$ 103.35 1.55 ▲ 1,004,519 $ 103.50
$ 102.09
$ 105.82
$ 84.17
12.5 31,792,837,050
Auspex Pharmaceuticals, Inc.
ASPX: NASDAQ-GM
$ 100.95 0.06 ▲ 284,988 $ 100.97
$ 100.92
$ 100.99
$ 14.75
NE 3,095,530,800
Esperion Therapeutics, Inc.
ESPR: NASDAQ-GM
$ 100.40 5.27 ▲ 576,088 $ 100.71
$ 96.721
$ 118.95
$ 12.76
NE 2,050,770,400
Johnson & Johnson
JNJ: NYSE
$ 100.13 0.93 ▲ 6,243,326 $ 100.39
$ 99.62
$ 109.49
$ 95.10
17.91 278,417,472,800
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 95.74 3.40 ▲ 464,077 $ 95.96
$ 92.50
$ 138.85
$ 31.51
NE 3,563,251,320